Periodic Reporting for period 1 - Proceed (Pharmacoepigenetics for precision medicine in type 2 diabetes)

The prevalence of diabetes will rise to ~592 million in 2035. Type 2 diabetes (T2D) is a leading cause of death through its vascular complications. High glucose increases the risk for complications, and thereby suffering for patients and costs for society. It is important that...